Skip to main content

ARIEL

About ARIEL

ARIEL is a clinical trial looking at whether extra tests on cancer samples can identify more patients with bowel/colon cancer who should be treated with drugs called anti-EGFR agents.

This website is intended to help:

  1. Patients and the public who want to know more about ARIEL – use the For Patients link above
  2. Healthcare professionals – use the For Researchers link above
 

Available at
32
UK hospitals

 

22
participants
recruited